Bleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors

dc.article.end-page86en
dc.article.start-page78en
dc.citation.doi10.1111/HAE.15109en
dc.contributor.authorA Dunnen
dc.contributor.authorY Dargauden
dc.contributor.authory Abajasen
dc.contributor.authorM Carcaoen
dc.contributor.authorE et alen
dc.contributor.authorJohnny Mahlanguen
dc.date.accessioned2025-08-26T10:02:20Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1351-8216en
dc.identifier.urihttps://hdl.handle.net/10539/46069
dc.journal.titleBleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitorsen
dc.journal.volume31en
dc.titleBleed treatment with eptacog beta rFVIIa results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitorsen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
672.41 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client